AL
CLVS

Airain Ltd’s Clovis Oncology, Inc. CLVS Stock Holding History

Airain Ltd’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$539K Buy
+5,761
New +$353K 0.02% 525
2013
Q4 		– Sell
-7,885
Closed -$479K – 732
2013
Q3 		$479K Buy
+7,885
New +$559K 0.09% 252

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Airain Ltd's CLVS Position: Q2 2017 in Review

Airain Ltd opened a new position in Clovis Oncology, Inc. (CLVS) in Q2 2017: 5,761 shares worth $539K. The stake represents 0.02% of the portfolio and ranks #525 among its holdings. This is a return to the name: Airain Ltd previously reported a position in CLVS as recently as Q3 2013.

Airain Ltd first reported a position in CLVS in Q3 2013 and has held it in 2 quarters since. 271 funds tracked by Wall St. Rank hold CLVS as of Q2 2017.

  • Airain Ltd held 5,761 shares of Clovis Oncology, Inc. worth $539K as of Q2 2017.
  • Clovis Oncology, Inc. was a new Airain Ltd position in Q2 2017.
  • Clovis Oncology, Inc. made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #525 holding.
  • Airain Ltd first reported a position in Clovis Oncology, Inc. in Q3 2013 and has held it in 2 quarters since.
  • 271 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.